Portfolio (Quarterly)
Guide ↗
Ishara Investments LP
· CIK 0002111609| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 410,000.0 | $10.4M | 7.62% | +287K | +233.3% | $25.30 | +15.4% |
| 2 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 1,230,000.0 | $9.7M | 7.16% | +205K | +20.0% | $7.92 | +6.9% |
| 3 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 143,500.0 | $8.2M | 6.03% | +62K | +75.0% | $57.22 | +12.5% |
| 4 | — | PRAXIS PRECISION MEDICINES I | — | 22,550.0 | $7.5M | 5.55% | — | — | $334.79 | — |
| 5 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 205,000.0 | $6.8M | 5.03% | +31K | +17.6% | $33.39 | -22.6% |
| 6 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 164,000.0 | $6.1M | 4.47% | NEW | — | $37.11 | -9.6% |
| 7 | INSM | INSMED INC | Healthcare | 51,250.0 | $5.5M | 4.01% | NEW | — | $106.62 | +11.3% |
| 8 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 143,500.0 | $5.4M | 3.94% | NEW | — | $37.42 | +126.8% |
| 9 | ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | 1,025,000.0 | $5.0M | 3.65% | -205K | -16.7% | $4.85 | -22.9% |
| 10 | PCVX | VAXCYTE INC | Healthcare | 82,000.0 | $4.8M | 3.50% | +25K | +42.9% | $58.13 | +2.8% |
| 11 | ANNX | ANNEXON INC | Healthcare | 820,000.0 | $4.7M | 3.44% | +646K | +370.6% | $5.71 | -12.5% |
| 12 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 82,000.0 | $4.7M | 3.42% | -29K | -25.9% | $56.81 | +16.0% |
| 13 | TNXP | TONIX PHARMACEUTICALS HLDG C | Healthcare | 338,250.0 | $4.3M | 3.17% | NEW | — | $12.76 | +5.7% |
| 14 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 57,400.0 | $4.3M | 3.14% | NEW | — | $74.48 | +3.3% |
| 15 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 16,400.0 | $4.0M | 2.95% | -25K | -60.0% | $244.77 | -18.0% |
| 16 | CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | 205,000.0 | $3.4M | 2.47% | +63K | +44.4% | $16.39 | +5.6% |
| 17 | LXRX | LEXICON PHARMACEUTICALS INC | Healthcare | 1,271,000.0 | $3.1M | 2.24% | +369K | +40.9% | $2.40 | -5.1% |
| 18 | KURA | KURA ONCOLOGY INC | Healthcare | 276,750.0 | $3.0M | 2.23% | NEW | — | $10.97 | +15.9% |
| 19 | — | DBV TECHNOLOGIES S A | — | 184,500.0 | $3.0M | 2.22% | +82K | +80.0% | $16.40 | — |
| 20 | GMAB | GENMAB A/S | Healthcare | 102,500.0 | $2.8M | 2.07% | +20K | +25.0% | $27.47 | +20.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%